Project Grant HT94252410783
Award Date 7/15/24
Completion Date 7/14/27
Dollars Obligated $381K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
- This federal Project Grant award of $707,438 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award was made on July 15, 2024 with a performance period ending on July 14, 2027. The prime awardee is the University of Massachusetts Medical School's Grants and Contracts Administration Division, which will conduct the research at their...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $694,935 to Byomass Inc. to support the development of BYOM-1119 for the prevention and treatment of pancreatic cancer metastases and cachexia. The award, which runs from November 1, 2025 to October 31, 2027, will fund Byomass Inc.'s biomedical research and development efforts focused on innovative treatments for cancer-related conditions such as...
- The Defense Health Agency awarded a $522,477 Project Grant to Boston Medical Center Corporation (BMC) under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to define genetic vulnerabilities in pancreatic neuroendocrine tumors that rely on the alternative lengthening of telomeres pathway. This 3-year project grant runs from August 1, 2023 to July 31, 2026. A sub-award of an unspecified amount was provided to the Trustees of Boston...
- The University of Massachusetts Medical School (UMASS Medical) was awarded a $3,854,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced biomedical research targeting human respiratory viruses and host sequences with respiratory-active RNAs. The award, effective from September 1, 2025 to August 31, 2029, supports UMASS Medical's specialized expertise in infectious disease research, genetic studies, and...
- The University of Massachusetts Amherst will receive $570,810 through January 31, 2026 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The funding will support the university's applied research efforts to transform health care for service members and the public through innovative...
- The University of Massachusetts Amherst was awarded a $557,247 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from February 1, 2023 to January 31, 2026 to develop intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The Military Medical Research and Development program supports innovative medical research with...
- The federal Project Grant award of $670,000 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Massachusetts Medical School (UMASS Medical) to identify immunomodulatory targets of the TAZ/SRF signaling pathway in sarcomatoid renal cell carcinoma progression. The award period runs from September 1, 2025 through August 31, 2029. As a prominent academic medical center, UMASS Medical has extensive expertise in...
- The Defense Health Agency awarded a $268,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a digital informational and supportive care app for patients initiating neoadjuvant therapy for pancreatic ductal adenocarcinoma. The project, titled "PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant...
- This Project Grant award, totaling $757,212.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Massachusetts Medical School Grants and Contracts Administration Division for the "PRECLINICAL DEVELOPMENT OF AN ORAL NANOBODY PROPHYLACTIC TO PREVENT DIARRHEAL DISEASE." The funding will support research and development of an oral nanobody-based therapeutic to prevent diarrheal disease, with an award...
- The federal Project Grant award of $388,194.00 from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) supports research at The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." This project, with a performance period from July 1, 2025 to June 30, 2028, aims to advance biomedical research that can transform healthcare for military service members, veterans, and the broader public. The...